Study of Epratuzumab in Systemic Lupus Erythematosus

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2007

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Epratuzumab

Trial Locations (54)

Unknown

Birmingham

Tucson

Los Angeles

Upland

Farmington

Washington D.C.

Aventura

Chicago

Baltimore

New York

Syracuse

The Bronx

Durham

Winston-Salem

Gallipolis

Tulsa

Charleston

Dallas

Arlington

Edmonds

Brussels

Liège

Rio de Janeiro

Goiânia

Rio de Janeiro

São Paulo

Winnipeg

Hradec Králové

Olomouc

Prague

Paris

Toulouse

Erlangen

Heidelberg

Mannheim

München

Debrecen

Pécs

Ancona

Brescia

Amsterdam

Groningen

Leiden

Piešťany

Barcelona

Madrid

Santander

Seville

Leeds

Birmingham

London

Manchester

Newcastle upon Tyne

Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY